Inhibition of rat CYP1A2 and CYP2C11 by honokiol, a component of traditional Chinese medicine

J Li, M Li, B Sun, C Liu, J Ren, W Zhi, P Zhang… - European Journal of …, 2019 - Springer
Abstract Background and Objectives Honokiol, a major constituent isolated from Magnolia
officinalis, is regarded as a phytochemical marker and bioactive substance present in many …

Modulation of rat hepatic CYP1A and 2C activity by honokiol and magnolol: Differential effects on phenacetin and diclofenac pharmacokinetics in vivo

SB Kim, KS Kim, HM Ryu, SH Hong, BK Kim, DD Kim… - Molecules, 2018 - mdpi.com
Honokiol (2-(4-hydroxy-3-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol) and magnolol (4-Allyl-
2-(5-allyl-2-hydroxy-phenyl) phenol) are the major active polyphenol constituents of …

Inhibition of CYP450 activity by honokiol and other four components of Chinese traditionalmedicine in vitro

P ZHANG, J REN, W ZHI, C LIU… - Chinese Journal of …, 2017 - manu41.magtech.com.cn
AIM: To explore the inhibition of honokiol and other four components of Chinese traditional
medicine on four kinds of cytochrome P450 activity in human liver microsomes (HLM) and …

Inhibition of magnolol and honokiol on cytochrome P450 enzymes in rat and human liver microsomes

J Duan, J Xiao, Y Chen, F Han - Chinese Herbal Medicines, 2015 - Elsevier
Objective The purpose of this work is to evaluate the in vitro inhibitory effect of magnolol
(MN) and honokiol (HN) on rat/human cytochrome P450 (CYP) enzymes (1A2/1A2, 2D/2D6 …

In vitro metabolism of magnolol and honokiol in rat liver microsomes and their interactions with seven cytochrome P substrates

Y Huang, C Liu, S Liu, Z Liu, S Li… - … in Mass Spectrometry, 2019 - Wiley Online Library
Rationale Magnolol and honokiol are the main active components of Magnolia officinalis
Rehd. et Wils. The study of their interactions with liver microsomes is very important for the …

Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes

HU Jeong, TY Kong, SS Kwon, SW Hong, SH Yeon… - Molecules, 2013 - mdpi.com
Honokiol is a bioactive component isolated from the medicinal herbs Magnolia officinalis
and Magnolia grandiflora that has antioxidative, anti-inflammatory, antithrombotic, and …

Inhibitory effect of honokiol and magnolol on cytochrome P450 enzyme activities in human liver microsomes

J Joo, KH Liu - Mass Spectrometry Letters, 2013 - oak.go.kr
Honokiol and magnolol, the major bioactive neolignans of magnolia officinalis, are the most
important constituents of the crude drug prescriptions that are used in the therapy of …

In vitro metabolism and disposition of honokiol in rat and human livers

M Böhmdorfer, A Maier‐Salamon, B Taferner… - Journal of …, 2011 - Elsevier
The biotransformation of honokiol, a major constituent of the bark of Magnolia officinalis, was
investigated in rat and human livers. When isolated, rat livers were perfused with 10 µM …

Metabolic interactions of magnolol with cytochrome P450 enzymes: Uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C

SB Kim, HE Kang, HJ Cho, YS Kim… - Drug Development …, 2016 - Taylor & Francis
Abstract Magnolol (MAG; 5, 5′-diallyl-2, 2′-biphenyldiol) is a major bioactive component
of Magnolia officinalis. We investigated the metabolic interactions of MAG with hepatic …

Effect of honokiol on the induction of drug-metabolizing enzymes in human hepatocytes

YY Cho, HU Jeong, JH Kim, HS Lee - Drug design, development …, 2014 - Taylor & Francis
Honokiol, 2-(4-hydroxy-3-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol, an active component of
Magnolia officinalis and Magnolia grandiflora, exerts various pharmacological activities such …